Nicolaas Visser

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Akzo Nobel N.v., Akzo N.v., Intervet Inc.. Active years: 1988-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolaas Visser. Retrieved from https://idiyas.com/inventor/nicolaas-visser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 88.9

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 132(Granted Patents)

Company Filing History:

Years Active: 1988-2016

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9408804 - Method for keeping an immunogenic composition available for administration to an animal (2016-08-09),

2. 7060282 - Attenuated equine herpesvirus (2006-06-13),

3. 6425879 - Needle-less injector (2002-07-30),

4. 6033844 - Porcine reproduction respiratory syndrome diagnostic (2000-03-07),

5. 5789388 - Vaccine against viruses associated with antibody-dependent-enhancement (1998-08-04),

6. 5698203 - European vaccine strains of the Porcine Reproductive Respiratory (1997-12-16),

7. 5626850 - Non-shedding live herpesvirus vaccine (1997-05-06),

8. 5080896 - Synthetic immunogen (1992-01-14),

9. 4788056 - Combined vaccine for viral and bacterial infections (1988-11-29),

Title: The Innovative Contributions of Nicolaas Visser

Introduction

Nicolaas Visser is a notable inventor based in Boxmeer, Netherlands. He has made significant contributions to the field of immunology, holding a total of nine patents. His work focuses on developing methods and compositions that enhance the administration of immunogenic substances to animals.

Latest Patents

One of Visser's latest patents is a method for keeping an immunogenic composition available for administration to an animal. This invention involves a composition that includes an antigen and a single emulsion, which can reverse at a specific temperature range. The method includes freezing the composition and storing it until needed for administration. Another significant patent relates to attenuated equine herpesvirus (EHV) mutants. These mutants have modifications in the endogenous promoter region of an essential viral gene, making them suitable for use in live vaccines due to their reduced virulence.

Career Highlights

Throughout his career, Nicolaas Visser has worked with prominent companies such as Akzo Nobel N.V. and Akzo N.V. His experience in these organizations has contributed to his expertise in the field of immunology and vaccine development.

Collaborations

Visser has collaborated with notable individuals in his field, including Petrus Alphonsus Van Woensel and Volker Ohlinger. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Nicolaas Visser's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, particularly in the development of vaccines and immunogenic compositions.

Profile summary based on public USPTO records.